RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 50 filers reported holding RAIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $196,595 | -27.0% | 228,121 | +1.6% | 0.00% | – |
| Q2 2023 | $269,485 | -44.0% | 224,571 | +307.8% | 0.00% | – |
| Q1 2023 | $481,251 | -2.9% | 55,063 | -11.1% | 0.00% | – |
| Q4 2022 | $495,408 | +334.6% | 61,926 | +164.0% | 0.00% | – |
| Q3 2022 | $114,000 | -12.3% | 23,458 | 0.0% | 0.00% | – |
| Q2 2022 | $130,000 | -86.6% | 23,458 | -87.8% | 0.00% | – |
| Q1 2022 | $972,000 | -44.1% | 191,801 | +42.0% | 0.00% | – |
| Q4 2021 | $1,740,000 | +3.3% | 135,078 | +20.0% | 0.00% | – |
| Q3 2021 | $1,684,000 | +21.6% | 112,541 | +26.3% | 0.00% | – |
| Q2 2021 | $1,385,000 | – | 89,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |